The enhanced community quarantine (ECQ) implemented from March 17 to May 30, 2020, in Metro Manila due to the COVID-19 pandemic had a tremendous impact on our society. However, the predicament among patients with preexisting conditions such as diabetics is of greater concern. Medical facilities were overwhelmed by the needs of COVID-19 patients, and patients having other medical conditions were discouraged from casually visiting the hospital for consultation due to the risk of acquiring COVID-19 infection. An online cross-sectional survey was conducted among 107 diabetic participants aged 22 to 76 years. This study aimed to describe the plight of diabetics regarding their disease before and during the ECQ. Through this study, challenges and coping capabilities were identified. The survey revealed that, prior to the pandemic, diabetic patients were already having difficulty following their treatment regimen despite awareness of the benefits of following it. During the ECQ, patients with high educational attainment and financial capability also had insecurities regarding the adequacy of medication and glucose test strip supplies, maintaining the recommended level of physical activity, and access to medical attention. Majority of the participants continued to rely on personal out-of-pocket expenditure during the ECQ despite the government’s amelioration program.
Keywords: COVID-19, diabetes mellitus, enhanced community quarantine, Metro ManilaAmerican Diabetes Association. (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care, 34(Suppl 1), S62–S69. doi:10.2337/dc11-S062
Arcellana, A. E., & Jimeno, C. (2020). Challenges and opportunities for diabetes care in the Philippines in the time of the COVID-19 pandemic. Journal of the ASEAN Federation of Endocrine Societies, 35(1), 55–57. doi:10.15605/jafes.035.01.04
Bayanihan to Heal as One Act, Republic Act No. 11469 (2020).
Beldomenico, P. M. (2020). Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19. International Journal of Infectious Diseases, 96, 461–463.
Centre for Evidence-Based Medicine. (2020, April 8). Managing diabetes during the COVID-19 pandemic. Retrieved from https://www.cebm.net/covid-19/managing-diabetes-during-the-covid-19-pandemic
Dale, B., & Stylianou, N. (2020, June 17). Coronavirus: What is the true death toll of the pandemic? BBC News. Retrieved from https://www.bbc.com/news/world-53073046
Davidson, J. A. (2020, May 14). Diabetes and COVID-19: 5 tips to stay well during the pandemic. UT Southwestern Medical Center. Retrieved from https://utswmed.org/medblog/diabetes-covid-19-risks/
European Center for Disease Prevention and Control. (2020). Clinical questions about COVID-19: Questions and answers. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html#Transmission
Haw, N., Uy, J., Sy, K., & Abrigo, M. (2020). Epidemiological profile and transmission dynamics of COVID-19 in the Philippines. Epidemiology and Infection, 148, e204. doi:10.1017/S0950268820002137
Hostalek, U., Gwilt, M., & Hildemann, S. (2015). Therapeutic use of metformin in prediabetes and diabetes prevention. Drugs, 75(10), 1071–1094. doi:10.1007/s40265-015-0416-8
Hussain, A., Bhowmik, B., & do Vale Moreira, N. C. (2020, April 6). COVID-19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144611/
International Diabetes Federation. (2020, March 11). COVID-19 and diabetes. Retrieved from https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes/1-covid-19-and-diabetes.html
International Diabetes Foundation. (2020, April 15). COVID-19 outbreak: Guidance for people with diabetes. Retrieved from https://www.idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html
Lewnard, J. A., & Lo, N. C. (2020). Scientific and ethical basis for social-distancing interventions against COVID-19. The Lancet Infectious Diseases, 20(6), 631–633. doi:10.1016/S1473-3099(20)30190-0
Maher, H. M., Abdelrahman, A. E., Alzoman, N. Z., & Aljohar, H. I. (2019). Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets. Journal of Liquid Chromatography & Related Technologies, 42(5–6), 161–171.
Mathew, T. K., & Tadi, P. (2020, August 14). Blood glucose monitoring. StatPearls. Treasure Island, FL: StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK555976/
Minnesota Department of Health. (2020, May 19). Staying active during the COVID-19 pandemic. Retrieved from https://www.health.state.mn.us/communities/physicalactivity/covid19.html
O’Keefe Osborn, C. (2019, January 14). Type 1 and type 2 diabetes: What’s the difference? Retrieved from https://www.healthline.com/health/difference-between-type-1-and-type-2-diabetes#causes
Peric, S., & Stulnig, T. M. (2020). Diabetes and COVID-19. Wiener Klinische Wochenschrift, 132(13), 356–361.
Permanente, K. (2017, June 13). Importance of taking diabetes medications as prescribed, exercising and managing weight. Science Daily. Retrieved from https://www.sciencedaily.com/releases/2017/06/170613102019.htm#:~:text=Summary%3A,according%20to%20a%20new%20study
Rhee, S. Y., Kim, H. J., Ko, S. H., Hur, K. Y., Kim, N. H., Moon, M. K., Committee of Clinical Practice Guideline of Korean Diabetes Association. (2017). Monotherapy in patients with type 2 diabetes mellitus. Diabetes & Metabolism Journal, 41(5), 349–356. doi:10.4093/dmj.2017.41.5.349
Schütt, M., Kern, W., Krause, U., Busch, P., Dapp, A., Grziwotz, R.,…DPV Initiative. (2006). Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 114(7), 384–388. doi:10.1055/s-2006-924152
Stoppler, M. C. & Ferry, R., Jr. (2019, August 27). Blood sugar levels in adults with type 1 or type 2 diabetes facts. MedicineNet. Retrieved from https://www.medicinenet.com/normal_blood_sugar_levels_in_adults_with_diabetes/article.htm
The Global Diabetes Community. (2019, January 15). How often do I need to test my blood glucose? Diabetes.co.uk. Retrieved from https://www.diabetes.co.uk/diabetes_care/how-often-should-i-blood-test.html
The Lancet. (2020, March). COVID-19: Learning from experience. The Lancet, 365, 1011. doi:10.1016/S0140-6736(20)30686-3
Thompson, D., Jr. (2010, April 21). When should you test your blood sugar? Everyday Health. Retrieved from https://www.everydayhealth.com/diabetes/type2/managing/when-to-check.aspx
Woods, J. A., Hutchinson, N. T., Powers, S. K., Roberts, W. O., Gomez-Cabrera, M. C., Radak, Z.,…Ji, L. L. (2020). The COVID-19 pandemic and physical activity. Sports Medicine and Health Science, 2(2), 55–64. doi:10.1016/j.smhs.2020.05.006
World Health Organization. (2017). Global report on diabetes. Geneva: World Health Organization, 2016.
World Health Organization. (2020a, April 1). Coronavirus disease (COVID-19) situation report 13. Retrieved from https://www.yumpu.com/en/document/read/63190921/who-phl-sitrep-13-covid-19-1apr2020
World Health Organization. (2020b, February 13). WHO supports the Philippine government in COVID-19 response? Retrieved from https://www.who.int/philippines/news/feature-stories/detail/who-supports-the-philippine-government-in-covid-19-response
World Health Organization. (n.d.). Naming the coronavirus disease (COVID-19) and the virus that causes it. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Yi Chi, W., Ching-Sung, C., & Yu-Jiun, C. (2020, March). The outbreak of COVID-19. Journal of the Chinese Medical Association, 83, 217–220. doi:10.1097/JCMA.00